Winston-Salem, NC-May 3, 2017- Charter Medical Ltd., a Fenner PLC subsidiary (LSE:FENR), a globally recognized manufacturer of products for the regenerative medicine and bioprocessing industries, announced today that it has established a strategic partnership with INCELL Corporation, an innovative developer and manufacturer of specialty medias and formulated solutions for tissue and cell collection, transport, processing and storage. The partnership will enable both organizations to meet the growing customer demand for more comprehensive solutions in cell culture, cell expansion, and cryopreservation.
- Charter Medical Announces Completion of Major Rebranding Initiative
- Charter Medical Announces Exclusive Global Distribution Agreement with INCELL Corporation
- Charter Medical Receives CE Mark for New Fluid Transfer Set Product Line Designed and Intended to Support the Cell Therapy Industry
- New Product from Charter Medical Designed to Enhance Commercial Production of Biotherapeutics
- Fenner Buys Charter Medical